Interpace Biosciences, Inc. Share Price
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Delayed
OTC Markets
11:57:14 12/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.670 USD | +0.06% |
|
+11.52% | +35.75% |
| Market Cap | 4.63Cr 4.01Cr 3.76Cr 3.43Cr 6.44Cr 441.23Cr 6.54Cr 44Cr 17Cr 220.93Cr 17Cr 17Cr 736.68Cr | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 4.49Cr 3.89Cr 3.65Cr 3.33Cr 6.26Cr 428.62Cr 6.35Cr 43Cr 17Cr 214.62Cr 17Cr 17Cr 715.63Cr | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.06% | ||
| 1 week | +11.52% | ||
| Current month | +10.09% | ||
| 1 month | +1.83% | ||
| 3 months | -16.50% | ||
| 6 months | -9.73% | ||
| Current year | +35.75% |
| 1 week | 1.61 |  | 1.7 |
| 1 month | 1.34 | | 1.7 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.77 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.33 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 01/12/2020 |
| Director of Finance/CFO | 34 | 21/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 21/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 01/01/2016 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 22/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/01/26 | Ampersand Management LLC
| Conversion | Company | 1,38,61,386 | 313.0013% | |
| 20/01/26 | 1315 Capital LLC
| Conversion | Company | 94,05,941 | 212.3938% | |
| 01/02/24 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | +11.52% | +77.35% | -7.22% | 4.63Cr | |
| -1.61% | +17.75% | +98.15% | +449.08% | 4.55TCr | |
| +0.21% | +2.45% | +18.98% | +48.76% | 2.62TCr | |
| +0.45% | +0.72% | -19.86% | -33.75% | 779.54Cr | |
| +1.21% | +14.11% | +13.70% | +145.83% | 605.58Cr | |
| +0.77% | +2.10% | +19.46% | +73.73% | 342.13Cr | |
| -0.22% | +18.86% | -32.81% | +1,484.58% | 245.71Cr | |
| +0.18% | +6.65% | +165.95% | +19.05% | 210.96Cr | |
| -3.78% | +8.88% | -0.10% | -52.11% | 207.94Cr | |
| +8.65% | +4.52% | +29.21% | +20.57% | 191.94Cr | |
| Average | +0.59% | +7.84% | +37.00% | +214.85% | 976.62Cr | |
| Weighted average by Cap. | -0.50% | +9.28% | +54.18% | +268.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.69Cr 4.07Cr 3.81Cr 3.47Cr 6.53Cr 447.57Cr 6.63Cr 45Cr 18Cr 224.11Cr 18Cr 17Cr 747.28Cr | 3.87Cr 3.36Cr 3.14Cr 2.87Cr 5.39Cr 369.38Cr 5.47Cr 37Cr 14Cr 184.96Cr 15Cr 14Cr 616.73Cr |
| Net income | 67.02L 58.07L 54.4L 49.62L 93.29L 64Cr 94.73L 6.4Cr 2.5Cr 32Cr 2.52Cr 2.46Cr 106.73Cr | 2.46Cr 2.13Cr 1.99Cr 1.82Cr 3.42Cr 234.39Cr 3.47Cr 23Cr 9.17Cr 117.36Cr 9.23Cr 9.03Cr 391.35Cr |
| Net Debt | 43.95L 38.08L 35.68L 32.54L 61.18L 42Cr 62.12L 4.2Cr 1.64Cr 21Cr 1.65Cr 1.61Cr 70Cr | -13.22L -11.45L -10.73L -10L -18.4L -13Cr -18.69L -1.26Cr -49.34L -6.31Cr -49.64L -48.56L -21Cr |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | $1.670 | +0.06% | 2,103 |
| 11/26/11 | $1.669 | -1.82% | 18,248 |
| 10/26/10 | $1.700 | +5.59% | 13,703 |
| 07/26/07 | $1.610 | -1.83% | 501 |
| 06/26/06 | $1.640 | +9.52% | 1,300 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
